“MOLECULAR MARKERS IN AML: PROGNOSTC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026087, Oct. 2026, doi: 10.4084/MJHID.2026.087.